Showing 2551-2560 of 4063 results for "".
- Clearside Biomedical Announces Positive Results in Safety, Durability and Biologic Effect in OASIS Phase 1/2a Clinical Trial of Suprachoroidal CLS-AX in Wet AMD Patientshttps://modernod.com/news/clearside-biomedical-announces-positive-results-in-safety-durability-and-biologic-effect-in-oasis-phase-12a-clinical-trial-of-suprachoroidal-cls-ax-in-wet-amd-patients/2481234/Clearside Biomedical announced positive results from its OASIS phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector in wet age-related macular degeneration (AMD) patients. Trial results include f
- Apellis Announces Plans to Submit 24-Month Phase 3 Data to the FDA for Pegcetacoplan NDA for Geographic Atrophy (GA)https://modernod.com/news/apellis-announces-plans-to-submit-24-month-phase-3-data-to-the-fda-for-pegcetacoplan-nda-for-geographic-atrophy-ga/2481233/Apellis Pharmaceuticals provided an update on its new drug application (NDA) for intravitreal pegcetacoplan for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The company plans to submit the 24-month efficacy data from the phase 3 DERB
- The Vision Council Releases Focused inSights 2022: Digital Habitshttps://modernod.com/news/the-vision-council-releases-focused-insights-2022-digital-habits/2481225/The Vision Council has released "Focused inSights 2022: Digital Habits." The survey asked respondents how they use digital devices, if they were affected by digital eyestrain, their online purchasing habits, their social media use, and their experience with telehealth for eye care. The
- Market Scope: Safer and More Effective Glaucoma Surgical Options Expected to Double Global Revenue by 2027https://modernod.com/news/market-scope-safer-and-more-effective-glaucoma-surgical-options-expected-to-double-global-revenue-by-2027/2481223/Nearly 48 million individuals are diagnosed with glaucoma globally, but just over a million, or 2.2 percent, will have surgery in 2022. However, safer and more effective surgical devices over the next 5 years will increase the percentage of glaucoma patients treated surgically to a projected 3.5
- Nanodropper Launches 2022 Give the Gift of Vision Campaign to Support Global Access to Eye Carehttps://modernod.com/news/nanodropper-launches-2022-give-the-gift-of-vision-campaign-to-support-global-access-to-eye-care/2481193/Nanodropper launched its "2022 Give the Gift of Vision" program, an effort to donate 1,000 Nanodropper adaptors to at-need patients in the United States and its global nonprofit partners—designed to deliver better access to vision-saving care in low resource settings in
- Nicox Provides Third Quarter 2022 Financial and Business Highlightshttps://modernod.com/news/nicox-provides-third-quarter-2022-financial-and-business-highlights/2481179/Nicox SA provided financial and business highlights for the third quarter of 2022 for Nicox SA and its subsidiaries (the “Nicox Group”) and confirmed timing for the upcoming NCX 470 Mont Blanc Phase 3 clinical trial milestone. Key Upcoming Milestone
- Aldeyra Therapeutics Achieves Primary Endpoint in Part 1 of Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathyhttps://modernod.com/news/aldeyra-therapeutics-achieves-primary-endpoint-in-part-1-of-phase-3-guard-trial-of-adx-2191-in-proliferative-vitreoretinopathy/2481155/Aldeyra Therapeutics announced the achievement of the primary endpoint in Part 1 of the phase 3 GUARD Trial of ADX-2191 (methotrexate injection, USP1) for intravitreal administration, an investigational drug candidate, for the prevention of proliferative vitreoretinopathy (PVR). ADX-21
- Haag-Streit Announces the Winners of the ‘Slit Lamp Imaging Competition 2022’https://modernod.com/news/haag-streit-announces-the-winners-of-the-slit-lamp-imaging-competition-2022/2481154/Haag-Streit has announced the winners of the ‘Haag-Streit Slit Lamp Imaging Competition 2022.' First place has been awarded to Utpal Sarkar from Disha Eye Hospitals Barrackpore in Kolkata, India. His winning image, taken with a Haag-Streit BX 900 slit lamp imaging sy
- Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meetinghttps://modernod.com/news/glaukos-technologies-featured-in-numerous-scientific-abstracts-at-the-2022-american-academy-of-ophthalmology-annual-meeting/2481136/Glaukos announced that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, being held September 30-October 3, 2022 in Chicago. Key Glaucoma Presentations: Bryan CH Ang, MD Novel
- Iridex to Showcase its Non-Incisional Treatments for Glaucoma and Introduce Sweep Management Software at AAO 2022https://modernod.com/news/iridex-to-showcase-its-non-incisional-treatments-for-glaucoma-and-introduce-sweep-management-software-at-aao-2022/2481130/Iridex will showcase non-incisional glaucoma treatments, introduce its Sweep Management Software, and host 8 physician presentations at the 2022 American Academy of Ophthalmology (AAO) annual meeting in Chicago, September 30 – October 3. MicroPulse Transscleral Laser Thera